Mike Tyson and Evander Holyfield to launch ‘Holy Ears’ cannabis-infused edibles

Mike Tyson and Evander Holyfield to launch ‘Holy Ears’ cannabis-infused edibles


Referee Lane Mills (C) stops the fight in the third round as Evander Holyfield (R) holds his ear as Mike Tyson (L) watches 28 June 1997 during their WBA heavyweight championship fight at the MGM Grand Garden Arena in Las Vegas, NV.

Jeff Haynes | AFP | Getty Images

Boxing legends and former rivals Mike Tyson and Evander Holyfield are teaming up to launch a line of cannabis-infused edibles called “Holy Ears.”

The collaboration was announced Monday and comes 25 years after the pair’s infamous heavyweight championship matchup, in which Tyson was disqualified for biting a chunk off of Holyfield’s ear.

The former opponents are reuniting under the newly formed cannabis company Carma Holdings, which also houses Tyson 2.0, Tyson’s existing cannabis company.

Tyson 2.0 already sells cannabis-infused products called Mike Bites, which are shaped like ears with a bite mark. Carma plans to release Holyfield’s own cannabis line in 2023.

“From Mike Bites to Holy Ears, now cannabis fans around the world can experience the same wellness benefits that plant-based products have brought me,” Tyson said in a statement, adding that it is a “privilege to reunite” with his former opponent.

“Mike and I have a long history of competition and respect for one another. And that night changed both of our lives. Back then, we didn’t realize that even as power athletes, we were also in a lot of pain,” Holyfield said in a statement. “Now, nearly 20 years later, we have the opportunity to share the medicine we really needed throughout our careers.”

Tyson 2.0 and Carma said Holy Ears products will be available starting this month online and at retail locations in Arizona, Illinois, Nevada and New Jersey. They will be offered in THC, Delta 8 and other hemp-cannabinoid varieties.

Last week, Carma Holdings also said it would house a cannabis product line by former wrestler Ric Flair.



Source

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More
American Express, credit card provider to the wealthy, wants even more high spenders
Business

American Express, credit card provider to the wealthy, wants even more high spenders

American Express announces the new platinum business card. Courtesy: American Express American Express is finding that even for a provider of credit cards to the affluent, it pays to focus on the highest of high rollers. The company recently shifted marketing dollars to its refreshed Platinum card, which carries an $895 annual fee, and away […]

Read More